Author: Sree Roy

Avadel Pharmaceuticals Makes Interim CEO Its New CEO

Avadel Pharmaceuticals plc, a company focused on developing FT218 for narcolepsy, has appointed Gregory J. Divis as CEO and member of the board of directors. Divis has served as interim CEO since January 2019. “Since being named...

Read More